China News Service, July 13 (Xinhua) According to the website of the National Health and Health Commission, the General Office of the National Health and Health Commission recently issued the "Notice of the General Office of the National Health and Health Commission on Laboratory Biosafety Supervision and Management in the Normalization of New Coronary Pneumonia Outbreaks" "(Hereinafter referred to as "Notice"), put forward requirements for the laboratory biosafety supervision and management. The "Notice" requires that each provincial health administrative department should enhance the laboratory's biosafety supervision capacity, carry out laboratory biosafety supervision in accordance with the principles of localization and classification, and strengthen the supervision and inspection of the new coronavirus experimental activities.

  "Notice" requires strict implementation of the new coronavirus experimental activity management requirements. According to the transmission characteristics, pathogenicity and clinical data of the new coronavirus (hereinafter referred to as the new coronavirus), the virus is managed according to the second category of pathogenic microorganisms. The local health administrative departments should require biosafety laboratories to carry out relevant experimental activities in strict accordance with protection requirements: the cultivation of new coronavirus and animal infection experiments should be carried out in laboratories of biosafety level 3 and above; the operation of uncultivated infectious materials should be carried out at Biosafety Level 2 and above laboratories, and use personal protection not less than Biosafety Level 3 laboratories; the operation of inactivating materials should be performed in biosafety Tier 2 and above laboratories; operations that do not involve infectious materials, It can be carried out in a biosafety laboratory.

  The "Notice" clearly stipulates that the laboratory biosafety services shall be guaranteed and regulated. The local health administrative departments should do a good job in the management of the filing of the testing laboratory, compact the responsibility of setting up the main body of the laboratory, urge the relevant units to strengthen the training and evaluation of experimental operation technology, personal protection, and disposal of test samples, and standardize the experimental staff of the new crown virus Sample testing operation process to improve testing capabilities and ensure the safety of testing personnel and surrounding environment.

  The "Notice" requires that the management of new coronavirus strains and related samples be strengthened. The transportation of new coronavirus strains and potentially infectious materials shall be managed in accordance with the Regulations on the Transportation of Species or Samples of Highly Pathogenic Microorganisms (Poisons) Infecting Humans. In accordance with the needs of the epidemic prevention and control situation in various regions, in the transportation link, the test samples of the "exhaustive inspection" personnel are strictly managed in accordance with the samples of highly pathogenic pathogenic microorganisms; the samples of the "willing inspection and inspection" personnel are shipped out of the unit through the samples After the risk assessment by the Biosafety Expert Committee, it can be managed according to ordinary samples. The scope of the personnel that should be inspected and inspected is in accordance with the Guiding Opinions. Provincial health administrative departments should strengthen the supervision and management of the strains and related sample storage units, and strictly prevent and prevent unauthorized transportation without approval.

  Provincial health and health administrative departments shall promptly study and put forward opinions on the disposal of biological samples for the detection of new coronavirus laboratory according to the needs of epidemic prevention and control and the requirements of laboratory biological safety. For those that really need to be preserved, they should be designated as soon as possible by the institutions that have the conditions for preservation to be preserved according to the principle of relative concentration, or sent to the national-level bacteria (poison) species preservation center for preservation; for those that do not need to be preserved, the relevant institutions should deal with them in accordance with the relevant biosafety requirements in a timely manner .

  Provincial health administrative departments should urge high-level biosafety laboratories within their jurisdiction to report new coronavirus strains to the National Health and Health Commission for science and education, and guide the laboratories to isolate new coronavirus strains. Within 90 days, apply for deposit to the National Class Bacteria (Poison) Seed Collection Center, and send the new coronavirus strain to the depositary institution for deposit after completing the relevant experimental activities. Provincial health and health administrative departments when handling the quasi-shipment procedures for the provision of new coronavirus strains or vaccine strains that use the new coronavirus as the parent virus to other laboratories or foreign institutions by depositing institutions of various types of bacteria (viruses) , To provide a copy of the quasi-transport certificate to the Department of Science and Education of the National Health and Health Commission in a timely manner.

  The "Notice" stipulates that each provincial health administrative department should effectively strengthen the organization and leadership, enhance the laboratory's biosafety supervision capabilities, carry out laboratory biosafety supervision in accordance with the principles of territorialization and classification, and strengthen the supervision and inspection of the new coronavirus experimental activities. Guide relevant organizations within the jurisdiction to strengthen biosafety management, strictly carry out experimental activities in accordance with the "Regulations on Pathogenic Microbiology Laboratory Biosafety Management" and related technical specifications to prevent laboratory leaks or personnel infections, and ensure the safety of laboratory biosecurity.